Evidence map›Paper›PMID 34011199›Full record

ArticleClinical trials (London, England)2021

A telehealth-based randomized controlled trial: A model for outpatient trials of off-label medications during the COVID-19 pandemic.

Salomeh Keyhani, J Daniel Kelly, Stephen Bent, W John Boscardin, Michael G Shlipak, Sam Leonard, Ann Abraham, Emily Lum, Nicholas Lau, Charles Austin and 6 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical trials (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Salomeh KeyhaniDepartment of Medicine, University of California, San Francisco, CA, USA.ORCID 0000-0001-9124-9618
J Daniel KellyDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
Stephen BentDepartment of Medicine, University of California, San Francisco, CA, USA.
W John BoscardinDepartment of Medicine, University of California, San Francisco, CA, USA.
Michael G ShlipakDepartment of Medicine, University of California, San Francisco, CA, USA.
Sam LeonardNorthern California Institute for Research and Education, The Veterans Health Research Institute, San Francisco, CA, USA.
Ann AbrahamUC San Francisco and UC Berkeley Joint Medical Program, San Francisco, CA, USA.
Emily LumNorthern California Institute for Research and Education, The Veterans Health Research Institute, San Francisco, CA, USA.
Nicholas LauNorthern California Institute for Research and Education, The Veterans Health Research Institute, San Francisco, CA, USA.
Charles AustinVA HSR&D Center for Health Information and Communication, Indianapolis, IN, USA.
Catherine E OldenburgDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
Allan ZillichVA HSR&D Center for Health Information and Communication, Indianapolis, IN, USA.
Lenny LopezDepartment of Medicine, University of California, San Francisco, CA, USA.
Ying ZhangDepartment of Biostatistics, College of Public Health University of Nebraska Medical Center, Omaha, NE, USA.
Tom LietmanDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
Dawn M BravataCenter for Health Information and Communication (CHIC), Health Services and Development (HSR&D), U.S. Department of Veterans Affairs (VA), Washington, DC, USA.

Funding

Marijuana Use in Older Adults: Health, Function and Fall-Related InjuryR01AG058678 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI KEYHANI, SALOMEH · 2019 to 2023
$3.0M
Impact of marijuana on adherence, risk factor control and cardiovascular eventsR01HL130484 · NHLBI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI KEYHANI, SALOMEH · 2017 to 2020
$2.9M
Understanding the epidemiology and natural history of unrecognized Ebola virus infectionK23AI146268 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KELLY, JOHN DANIEL · 2019 to 2022
$748k
Risks of Cannabis Use Among Veterans on Long-term Opioid TherapyI01HX002737 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI KEYHANI, SALOMEH · 2020 to 2024
–
PRIS-M: Precision Monitoring to Transform CareIP1HX001994 · VA · RLR VA MEDICAL CENTER · PI BRAVATA, DAWN MARIE, DAMUSH, TERESA M. · 2019 to 2021
–
HSRD VA I01 HX002737HSRD VA IP1 HX001994NCI NIH HHS K23 AI135037NHLBI NIH HHS R01 HL130484NIAID NIH HHS K23 AI146268NIA NIH HHS R01 AG058678NIA NIH HHS R01 AG068678
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 Drug TreatmentPatient SelectionAmbulatory CareAnti-Bacterial AgentsArrhythmias, CardiacAzithromycinEnzyme InhibitorsHumansHydroxychloroquineRandomized Controlled Trials as TopicRisk AssessmentSARS-CoV-2TelemedicineUnited StatesUnited States Department of Veterans AffairsVeteransAnti-Bacterial AgentsAzithromycinEnzyme InhibitorsHydroxychloroquine

Identifiers

PMID34011199
PMCPMC8292190

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.